Rosuvastatin use reduces thrombin generation potential in patients with venous thromboembolism: a randomized controlled trial

ESSENTIALS: The role of statins in hemostasis and venous thromboembolism (VTE) prophylaxis is not clear. This trial assessed whether rosuvastatin use affects thrombin generation in patients with VTE. Endogenous thrombin potential and peak were decreased by 10% and 5% with rosuvastatin therapy. These...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Thromb Haemost
Autors principals: Orsi, Fernanda A., Biedermann, Joseph S., Kruip, Marieke J.H.A., van der Meer, Felix J., Rosendaal, Frits R., van Hylckama Vlieg, Astrid, Bos, Mettine H. A., Leebeek, Frank W. G., Cannegieter, Suzanne C., Lijfering, Willem M.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2019
Matèries:
CLINICAL HEMOSTASIS AND THROMBOSIS
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6850636/
https://ncbi.nlm.nih.gov/pubmed/30565854
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.14364
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars